Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
111.00    -7.00 (-5.93%)
Bid:
110.00
Ask:
112.00
Spread: 2.00 (1.818%)
Market Cap: £66.78m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

3 Mar 2017 07:00

RNS Number : 4066Y
Intercede Group PLC
03 March 2017
 

 

 

 

 

3 March 2017

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

 Trading Update

 

Following the Company's announcement on 5 January 2017 of the receipt of a record $3.0m order, the order book as of 2 March 2017 indicates that, unless further orders are received that can be recognised as revenue in the current period, the revenue outturn for the financial year ending 31 March 2017 will be approximately £8.0m. A further £2.0m of new orders remain in the current period pipeline which includes US government and defence contractor customers.

The Company is working diligently to close these orders. However, the US Presidential Budget Proposal issued on 27 February 2017 made a commitment to radically increase military and infrastructure expenditure during the term of the new administration. This commitment has raised considerable and unexpected uncertainty for the short term budget allocations across the Company's target customer base in the US.

There remains a risk that a proportion of the outstanding orders forecast for closure in the current period will be delayed into the next financial year. The consequent impact on revenue is likely to result in losses for the year to 31 March 2017 being higher than management expectations. In this case, gross cash balances (excluding £4.5m convertible loan notes) are forecast to be approximately £6.0m as at 31 March 2017.

Intercede believes that the impact of the Presidential Budget will be short term in nature. Cybersecurity remains a vital component of US IT strategy and a Presidential Executive Order on Cybersecurity is expected shortly. Contemporaneously, New York State Cybersecurity Regulations for Financial Services Companies 23 NYCRR 500 became effective on 1 March 2017. In the medium to long term, the regulatory trend towards higher levels of cybersecurity will significantly increase budgets. As a result, it is highly probable that this could produce a step change in the Company's revenue potential within the US government and US regulated financial services markets.

Richard Parris, Chairman & CEO of Intercede, commented

"Following the Presidential Budget Proposal, the Board has taken a conservative view of its immediate pipeline. While we remain confident that these orders will flow to revenue, there can be no certainty that this will occur within the current financial year. This timing issue does not in any way detract from the Board's confidence in the Company's prospects. Intercede is developing products and services which directly address the emerging need for higher levels of cybersecurity. In the next 12 months, European and US regulation will require a range of agencies and organisations to put this in place. Intercede is already well advanced in its plans to benefit from this trend, utilising the £4.5m (net) funds raised in January 2017 to invest in new applications for our leading software and to expand into new markets. Intercede is reducing its dependence on single geographies and sectors which will position the Company well for what promises to be a period of potential growth."

 

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

Capital Access Group Tel. +44 (0)203 7633405

Scott Fulton

 

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWFWEFWSEED
Date   Source Headline
28th Feb 20197:00 amRNSNew Contract Win
4th Feb 20193:19 pmRNSHolding(s) in Company
17th Dec 201810:19 amRNSBoard Change
26th Nov 20187:00 amRNSHalf-year Report
22nd Oct 20187:00 amRNSGrant of Options
4th Oct 20187:00 amRNSTrading Statement
20th Sep 20187:00 amRNSResult of AGM
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSDirector/PDMR Shareholding
10th Jul 20188:00 amRNSDirector/PDMR Shareholding
29th Jun 20184:59 pmRNSPDMR Shareholding
7th Jun 20187:00 amRNSFinal Results
26th Apr 20182:10 pmRNSPDMR Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
20th Apr 201812:15 pmRNSPDMR Change
11th Apr 201811:36 amRNSHolding(s) in Company
11th Apr 20187:00 amRNSAppointment of Chief Executive
4th Apr 20187:00 amRNSReceipt of $4.0m Order/Trading Update
29th Mar 20187:00 amRNSDirectorate Change
9th Mar 20187:00 amRNSNew Contract Award
13th Feb 20187:00 amRNSNew Contract Award
4th Dec 20177:00 amRNSContract
30th Nov 20177:00 amRNSNew Contract Award
27th Nov 20177:00 amRNSHalf-year Report
6th Nov 20171:58 pmRNSTrading Update
26th Oct 20177:00 amRNSShare Award
5th Oct 20177:00 amRNSTrading Statement
13th Sep 20173:30 pmRNSResult of AGM
13th Sep 20177:00 amRNSDirectorate Change
25th Aug 20177:00 amRNSIssue of Convertible Loan Notes
1st Aug 20179:07 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSShare Incentive Plan & Issue of Equity
18th Jul 20177:00 amRNSDirector/PDMR Shareholding & TVR
13th Jun 20177:00 amRNSCollaborations with VMWare and Imagination
7th Jun 201712:06 pmRNSHolding(s) in Company
7th Jun 201712:01 pmRNSHolding(s) in Company
7th Jun 20177:00 amRNSFinal Results
6th Jun 20177:00 amRNSLaunch of MyIDaaS
25th May 20177:00 amRNSSchedule 2(g) Disclosure
23rd May 20177:00 amRNSAppointment of Chief Sales Officer
17th May 20177:00 amRNSNon-Executive Director Appointment
9th May 20177:00 amRNSContract Win
8th May 20173:45 pmRNSShare Incentive Plan
8th May 20177:00 amRNSIntercede announces Secure Login for WordPress
5th Apr 20177:00 amRNSTrading Update
31st Mar 20177:00 amRNSListing of Convertible Loan Notes
20th Mar 20177:00 amRNSAppointment of VP, US Gov't & Enterprise Sales
15th Mar 20173:03 pmRNSShare Incentive Plan
9th Mar 20177:00 amRNSAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.